Cargando…

Trends of Stem Cell Therapies in Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is a highly prevalent irreversible impairment in the elderly population worldwide. Stem cell therapies have been considered potentially viable for treating AMD through the direct replacement of degenerated cells or secretion of trophic factors that facilitate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maeda, Tadao, Sugita, Sunao, Kurimoto, Yasuo, Takahashi, Masayo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074076/ https://www.ncbi.nlm.nih.gov/pubmed/33923985 http://dx.doi.org/10.3390/jcm10081785

Ejemplares similares

Automated evaluation of retinal pigment epithelium disease area in eyes with age-related macular degeneration
por: Motozawa, Naohiro, et al.
Publicado: (2022)

Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes
por: Motozawa, Naohiro, et al.
Publicado: (2019)

Polarization-sensitive optical coherence tomography for estimating relative melanin content of autologous induced stem-cell derived retinal pigment epithelium
por: Matsuzaki, Mitsuhiro, et al.
Publicado: (2020)

Medication Trends for Age-Related Macular Degeneration
por: Cho, Yeon-Kyoung, et al.
Publicado: (2021)

HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration
por: Sugita, Sunao, et al.
Publicado: (2020)

Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning
por: Miyamoto, Noriko, et al.
Publicado: (2017)

Stem cell therapies for age-related macular degeneration: the past, present, and future
por: Dang, Yalong, et al.
Publicado: (2015)

Emerging options for the management of age-related macular degeneration with stem cells
por: Mooney, Ingrid, et al.
Publicado: (2010)

Radiation therapy for neovascular age-related macular degeneration
por: Petrarca, Robert, et al.
Publicado: (2011)

Cellular models and therapies for age-related macular degeneration
por: Forest, David L., et al.
Publicado: (2015)

Pipeline therapies for neovascular age related macular degeneration
por: Arepalli, Sruthi, et al.
Publicado: (2021)

Recent Advances in Age-Related Macular Degeneration Therapies
por: Fabre, Marie, et al.
Publicado: (2022)

Microglia dynamics in retinitis pigmentosa model: formation of fundus whitening and autofluorescence as an indicator of activity of retinal degeneration
por: Makabe, Kenichi, et al.
Publicado: (2020)

Future Therapies of Wet Age-Related Macular Degeneration
por: Ishikawa, Makoto, et al.
Publicado: (2015)

Present and Possible Therapies for Age-Related Macular Degeneration
por: Khan, Muhammad, et al.
Publicado: (2014)

Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration
por: Melville, Heather, et al.
Publicado: (2013)

Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa
por: Ludwig, Parker E., et al.
Publicado: (2019)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Metabolomics and Age-Related Macular Degeneration
por: Brown, Connor N., et al.
Publicado: (2018)

Nanotechnology for Age-Related Macular Degeneration
por: Yang, Bo, et al.
Publicado: (2021)

Age-Related Macular or Retinal Degeneration?
por: Gałuszka, Michalina, et al.
Publicado: (2023)

Treatment of neovascular age-related macular degeneration: Current therapies
por: Augustin, Albert J, et al.
Publicado: (2009)

Current and emerging therapies for the treatment of age-related macular degeneration
por: Emerson, M Vaughn, et al.
Publicado: (2008)

Age-related macular degeneration and the aging eye
por: Ehrlich, Rita, et al.
Publicado: (2008)

Pluripotent stem cells: A therapeutic source for age-related macular degeneration
por: Parameswaran, Sowmya, et al.
Publicado: (2017)

Successful Transplantation of Retinal Pigment Epithelial Cells from MHC Homozygote iPSCs in MHC-Matched Models
por: Sugita, Sunao, et al.
Publicado: (2016)

Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration
por: Akyol, Engin, et al.
Publicado: (2020)

Pharmacogenetics and Age-Related Macular Degeneration
por: Schwartz, Stephen G., et al.
Publicado: (2011)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
por: Samanta, Anindya, et al.
Publicado: (2020)

Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem (iPS) Cells Suppress or Activate T Cells via Costimulatory Signals
por: Sugita, Sunao, et al.
Publicado: (2020)

Bilateral retinitis after influenza virus infection in a case report
por: Ito, Shin-ichiro, et al.
Publicado: (2020)

Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

An update on the genetics of age-related macular degeneration
por: Scholl, Hendrik P.N., et al.
Publicado: (2007)

Age-related macular degeneration: current treatments
por: Hubschman, Jean Pierre, et al.
Publicado: (2009)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

Aflibercept for the Treatment of Age-Related Macular Degeneration
por: Trichonas, George, et al.
Publicado: (2013)

Angiofluorographic aspects in age-related macular degeneration
por: Tomi, A, et al.
Publicado: (2014)

Fundus Autofluorescence in Age-related Macular Degeneration
por: Ly, Angelica, et al.
Publicado: (2017)

Vitamin D and Age-Related Macular Degeneration
por: Garcia Layana, Alfredo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9uib5a1ecca3lm5m024jv1a4so